Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_10413 | 12 | 0.24 | Mlig455_053242, Mlig455_066367 | Neo: - Age: - |
LHFPL6 | Mlig455_053242 {REF} {Length: 1343} {Pfam: Lipoma HMGIC fusion partner-like protein [PF10242.11, score=114.6]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=21.4]; Lipid II flippase MurJ [PF03023.16, score=20.7]} {Human: ENSG00000183722, LHFPL6, LHFPL tetraspan subfamily member 6, [RH, Score=81.6, Expect=2e-17]} {Mouse: ENSMUSG00000048332, Lhfp, lipoma HMGIC fusion partner, [RH, Score=79.7, Expect=8e-17]} {Smed: dd_Smed_v6_9373_0_1, dd_Smed_v6_9373_0_1, [RH, Score=181, Expect=4e-53]} {RNA1310_36894} {RNA815_56428} Mlig455_066367 {REF} {Length: 1706} {Pfam: Lipoma HMGIC fusion partner-like protein [PF10242.11, score=114.6]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=21.4]; Lipid II flippase MurJ [PF03023.16, score=20.7]} {Human: ENSG00000183722, LHFPL6, LHFPL tetraspan subfamily member 6, [RH, Score=81.6, Expect=2e-17]} {Mouse: ENSMUSG00000048332, Lhfp, lipoma HMGIC fusion partner, [RH, Score=79.7, Expect=8e-17]} {Smed: dd_Smed_v6_9373_0_1, dd_Smed_v6_9373_0_1, [RH, Score=181, Expect=4e-53]} {RNA1509_28410} {RNA1310_83173.1} {RNA815_56428} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -1.794 | 0.723 | 1.00000 | 1.00000 | |
RegionR2 | -0.168 | 0.723 | 1.00000 | 1.00000 | |
RegionR3 | -0.973 | 0.723 | 1.00000 | 1.00000 | |
RegionR4 | 4.462 | 0.723 | 0.01659 | 0.08906 | |
RegionR5 | 1.823 | 0.723 | 0.06644 | 0.22972 | |
RegionR6 | -0.832 | 0.723 | 1.00000 | 1.00000 | |
RegionR7 | -1.359 | 0.723 | 1.00000 | 1.00000 | |
RegionR8 | -1.158 | 0.723 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 1.391 | 0.723 | 1.00000 | 1.00000 | |
RegenerationR2 | -0.552 | 0.723 | 0.92024 | 1.00000 | |
RegenerationR3 | 0.495 | 0.723 | 0.99557 | 1.00000 | |
RegenerationR4 | -2.096 | 0.723 | 0.07116 | 0.42422 | |
RegenerationR5 | -1.168 | 0.723 | 0.14204 | 0.55580 | |
RegenerationR6 | 0.779 | 0.723 | 0.94299 | 1.00000 | |
RegenerationBL | -1.106 | 0.723 | 0.99981 | 1.00000 | |
RegenerationTP | -1.509 | 0.723 | 1.00000 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_10413 | 12 | 0.24 | Mlig455_053242, Mlig455_066367 | Neo: - Age: - |
LHFPL6 | 2 | - | - | 1.000 | - | - | 1.000 | Mlig455_053242 {REF} {Length: 1343} {Pfam: Lipoma HMGIC fusion partner-like protein [PF10242.11, score=114.6]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=21.4]; Lipid II flippase MurJ [PF03023.16, score=20.7]} {Human: ENSG00000183722, LHFPL6, LHFPL tetraspan subfamily member 6, [RH, Score=81.6, Expect=2e-17]} {Mouse: ENSMUSG00000048332, Lhfp, lipoma HMGIC fusion partner, [RH, Score=79.7, Expect=8e-17]} {Smed: dd_Smed_v6_9373_0_1, dd_Smed_v6_9373_0_1, [RH, Score=181, Expect=4e-53]} {RNA1310_36894} {RNA815_56428} Mlig455_066367 {REF} {Length: 1706} {Pfam: Lipoma HMGIC fusion partner-like protein [PF10242.11, score=114.6]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=21.4]; Lipid II flippase MurJ [PF03023.16, score=20.7]} {Human: ENSG00000183722, LHFPL6, LHFPL tetraspan subfamily member 6, [RH, Score=81.6, Expect=2e-17]} {Mouse: ENSMUSG00000048332, Lhfp, lipoma HMGIC fusion partner, [RH, Score=79.7, Expect=8e-17]} {Smed: dd_Smed_v6_9373_0_1, dd_Smed_v6_9373_0_1, [RH, Score=181, Expect=4e-53]} {RNA1509_28410} {RNA1310_83173.1} {RNA815_56428} |
2. | MligTC455_21670 | 38 | 0.78 | Mlig455_032196, Mlig455_051153 | Neo: - Age: Down-Up-Up |
1.774 | - | - | 0.953 | - | - | 0.821 | Mlig455_032196 {REF} {Length: 2295} {Smed: dd_Smed_v6_12148_0_2, dd_Smed_v6_12148_0_2, [Score=84.0, Expect=8e-19]} {RNA1509_45032} {RNA1310_23524} {RNA815_16677} Mlig455_051153 {REF} {Length: 1989} {Smed: dd_Smed_v6_12148_0_2, dd_Smed_v6_12148_0_2, [Score=84.0, Expect=8e-19]} {RNA1509_45032} {RNA1310_23524} {RNA815_16677} |
|
3. | MligTC455_45862 | 69 | 1.44 | Mlig455_034443, Mlig455_066209 | Neo: - Age: - Region-enriched R2: 6.793/0.00003 |
1.769 | - | - | 0.817 | - | - | 0.952 | Mlig455_034443 {REF} {Length: 1138} {RNA1310_86023} Mlig455_066209 {REF} {Length: 1301} {RNA1310_86023} |
|
4. | MligTC455_42514 | 28 | 0.59 | Mlig455_027746 | Neo: - Age: Up-Down-Down |
KCNC2 | 0.988 | - | - | 0.988 | - | - | - | Mlig455_027746 {REF} {Length: 2596} {Pfam: Ion transport protein [PF00520.33, score=123.8]; BTB/POZ domain [PF02214.24, score=86.8]; Ion channel [PF07885.18, score=37.1]} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=284, Expect=2e-86]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=279, Expect=3e-85]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=270, Expect=2e-81]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=279, Expect=3e-85]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=270, Expect=2e-81]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=280, Expect=7e-87]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=303, Expect=3e-94]} {Smed: dd_Smed_v6_13250_0_1, dd_Smed_v6_13250_0_1, [Score=286, Expect=3e-88]} {RNA1509_33421} {RNA1310_15684} {RNA815_16308} |
5. | MligTC455_39719 | 44 | 0.92 | Mlig455_063602 | Neo: - Age: - |
MPDZ | 0.986 | - | - | 0.986 | - | - | - | Mlig455_063602 {REF} {Length: 2307} {Pfam: PDZ domain [PF00595.26, score=187.6]; PDZ domain [PF17820.3, score=85.4]; PDZ domain [PF13180.8, score=85.1]} {Human: ENSG00000107186, MPDZ, multiple PDZ domain crumbs cell polarity complex component, [Score=244, Expect=9e-70]} {Mouse: ENSMUSG00000028402, Mpdz, multiple PDZ domain protein, [Score=237, Expect=7e-67]} {Dmel: FBgn0263289, scrib, scribbled, [Score=88.6, Expect=6e-18]} {Celegans: WBGene00003404, mpz-1, Multiple PDZ domain protein, [Score=137, Expect=7e-35]} {Smed: dd_Smed_v6_4520_0_1, dd_Smed_v6_4520_0_1, [Score=147, Expect=2e-37]} {RNA1310_8275.3} {RNA815_16615} |
6. | MligTC455_07428 | 12 | 0.25 | Mlig455_055209 | Neo: - Age: - |
0.985 | - | - | 0.985 | - | - | - | Mlig455_055209 {REF} {Length: 759} {RNA1310_50531} {RNA815_29422} | |
7. | MligTC455_22356 | 28 | 0.57 | Mlig455_009532 | Neo: - Age: - Region-enriched R5: 4.548/0.03532 |
GALR2 | 0.984 | - | - | 0.984 | - | - | - | Mlig455_009532 {REF} {Length: 3801} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=72.4]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=50.8, Expect=6e-06]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=52.4, Expect=1e-06]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=50.1, Expect=3e-06]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [Score=126, Expect=3e-31]} {RNA1310_79397} {RNA815_39017} |
8. | MligTC455_29108 | 43 | 0.9 | Mlig455_052031 | Neo: - Age: logFC(26M/2M)=-0.764 |
0.984 | - | - | 0.984 | - | - | - | Mlig455_052031 {REF} {Length: 3111} {NoTransDecoderORF} {RNA1310_19531.2} {RNA815_10097} | |
9. | MligTC455_51760 | 18 | 0.38 | Mlig455_051796 | Neo: - Age: - |
CNBD2 | 0.981 | - | - | 0.981 | - | - | - | Mlig455_051796 {REF} {Length: 2614} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=74.7]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=67.4, Expect=2e-11]; ENSG00000185532, PRKG1, protein kinase cGMP-dependent 1, [Score=64.3, Expect=4e-10]} {Mouse: ENSMUSG00000052920, Prkg1, protein kinase, cGMP-dependent, type I, [Score=64.7, Expect=2e-10]; ENSMUSG00000038085, Cnbd2, cyclic nucleotide binding domain containing 2, [Score=63.9, Expect=2e-10]} {Dmel: FBgn0259243, Pka-R1, Protein kinase, cAMP-dependent, regulatory subunit type 1, [Score=57.4, Expect=1e-08]} {Celegans: WBGene00015650, pkg-2, Protein Kinase, cGMP-dependent, [Score=61.2, Expect=1e-09]} {Smed: dd_Smed_v6_17565_0_1, dd_Smed_v6_17565_0_1, [Score=174, Expect=1e-46]} {RNA1310_33768} {RNA815_47620} |
10. | MligTC455_24406 | 204 | 4.25 | Mlig455_043947 | Neo: - Age: - Region-specific R2: 3.852 Region-enriched R2: 3.953/0.00003 |
0.976 | - | - | 0.976 | - | - | - | Mlig455_043947 {REF} {Length: 1609} {RNA1509_54091} {RNA1310_68348.1, RNA1509_54091} {RNA1509_54091, RNA815_33570.1} | |
11. | MligTC455_34655 | 89 | 1.86 | Mlig455_058020, Mlig455_058176 | Neo: - Age: - Region-enriched R2: 5.798/0.00826 |
PPEF1 | 0.975 | - | - | 0.975 | - | - | - | Mlig455_058020 {REF} {Length: 3007} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=84.9]; EF-hand domain pair [PF13499.8, score=77.8]; EF hand [PF00036.34, score=66.0]; EF-hand domain pair [PF13833.8, score=52.1]; EF-hand domain [PF13405.8, score=48.4]; EF hand [PF13202.8, score=38.2]; PPP5 TPR repeat region [PF08321.14, score=37.0]; EF-hand domain [PF14658.8, score=23.0]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=20.4]} {Human: ENSG00000086717, PPEF1, protein phosphatase with EF-hand domain 1, [Score=416, Expect=2e-138]} {Mouse: ENSMUSG00000062168, Ppef1, protein phosphatase with EF hand calcium-binding domain 1, [Score=413, Expect=9e-138]} {Dmel: FBgn0265959, rdgC, retinal degeneration C, [Score=404, Expect=3e-134]} {Celegans: WBGene00003969, pef-1, Serine/threonine-protein phosphatase with EF-hands pef-1, [Score=455, Expect=2e-155]} {Smed: dd_Smed_v6_11874_0_2, dd_Smed_v6_11874_0_2, [Score=516, Expect=2e-178]} {RNA1509_3508} {RNA1310_10928.2} {RNA815_11707} Mlig455_058176 {REF} {Length: 3371} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=102.6]; EF-hand domain pair [PF13499.8, score=72.6]; EF hand [PF00036.34, score=64.2]; EF-hand domain pair [PF13833.8, score=51.3]; EF-hand domain [PF13405.8, score=46.1]; EF hand [PF13202.8, score=36.7]; PPP5 TPR repeat region [PF08321.14, score=36.6]; EF-hand domain [PF14658.8, score=26.5]; IQ calmodulin-binding motif [PF00612.29, score=21.3]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=19.8]} {Human: ENSG00000086717, PPEF1, protein phosphatase with EF-hand domain 1, [RH, Score=546, Expect=0.0]} {Mouse: ENSMUSG00000062168, Ppef1, protein phosphatase with EF hand calcium-binding domain 1, [Score=520, Expect=3e-177]} {Dmel: FBgn0265959, rdgC, retinal degeneration C, [Score=529, Expect=2e-180]} {Celegans: WBGene00003969, pef-1, Serine/threonine-protein phosphatase with EF-hands pef-1, [Score=598, Expect=0.0]} {Smed: dd_Smed_v6_11874_0_1, dd_Smed_v6_11874_0_1, [Score=671, Expect=0.0]} {RNA1509_3508} {RNA1310_10928.2} {RNA815_11707} |
12. | MligTC455_34815 | 30 | 0.63 | Mlig455_020979 | Neo: - Age: - |
0.973 | - | - | 0.973 | - | - | - | Mlig455_020979 {REF} {Length: 1394} {RNA1310_37266} | |
13. | MligTC455_25445 | 12 | 0.24 | Mlig455_021534 | Neo: - Age: Up-Down-Up |
CACNA1D | 0.972 | - | - | 0.972 | - | - | - | Mlig455_021534 {REF} {Length: 4880} {Pfam: Ion transport protein [PF00520.33, score=359.2]; Voltage gated calcium channel IQ domain [PF08763.13, score=102.5]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=91.9]} {Human: ENSG00000157388, CACNA1D, calcium voltage-gated channel subunit alpha1 D, [Score=971, Expect=0.0]; ENSG00000081248, CACNA1S, calcium voltage-gated channel subunit alpha1 S, [Score=957, Expect=0.0]; ENSG00000151067, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=944, Expect=0.0]; ENSG00000285479, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=944, Expect=0.0]} {Mouse: ENSMUSG00000015968, Cacna1d, calcium channel, voltage-dependent, L type, alpha 1D subunit, [Score=971, Expect=0.0]; ENSMUSG00000051331, Cacna1c, calcium channel, voltage-dependent, L type, alpha 1C subunit, [Score=959, Expect=0.0]; ENSMUSG00000026407, Cacna1s, calcium channel, voltage-dependent, L type, alpha 1S subunit, [Score=958, Expect=0.0]} {Dmel: FBgn0001991, Ca-alpha1D, Ca[2+]-channel protein alpha[[1]] subunit D, [Score=989, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=1053, Expect=0.0]} {Smed: dd_Smed_v6_8899_0_17, dd_Smed_v6_8899_0_17, [Score=1104, Expect=0.0]} {RNA1509_48072} {RNA1310_376.1} {RNA815_1126.1} |
14. | MligTC455_34656 | 48 | 1 | Mlig455_058210 | Neo: Irradiation Age: Up-Down-Down, logFC(26M/2M)=-0.537 Region-enriched R2: 5.874/0.03747 |
PPEF1 | 0.972 | - | - | 0.972 | - | - | - | Mlig455_058210 {REF} {Length: 2937} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=90.9]; EF-hand domain pair [PF13499.8, score=63.3]; EF hand [PF00036.34, score=53.9]; PPP5 TPR repeat region [PF08321.14, score=45.9]; EF-hand domain pair [PF13833.8, score=45.7]; EF-hand domain [PF13405.8, score=43.1]; EF hand [PF13202.8, score=41.7]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=20.2]} {Human: ENSG00000086717, PPEF1, protein phosphatase with EF-hand domain 1, [Score=533, Expect=0.0]} {Mouse: ENSMUSG00000062168, Ppef1, protein phosphatase with EF hand calcium-binding domain 1, [Score=512, Expect=1e-174]} {Dmel: FBgn0265959, rdgC, retinal degeneration C, [Score=489, Expect=6e-166]} {Celegans: WBGene00003969, pef-1, Serine/threonine-protein phosphatase with EF-hands pef-1, [Score=563, Expect=0.0]} {Smed: dd_Smed_v6_11874_0_1, dd_Smed_v6_11874_0_1, [Score=642, Expect=0.0]} {RNA1509_3508} {RNA1310_11714.1} {RNA815_4130} |
15. | MligTC455_44025 | 591 | 12.31 | Mlig455_050980 | Neo: - Age: - Region-specific R2: 5.366 Region-enriched R2: 5.986/0.00000 |
0.972 | - | - | 0.972 | - | - | - | Mlig455_050980 {REF} {Length: 587} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=49.7, Expect=7e-09]} {RNA1509_52032} {RNA1310_52449.2} {RNA815_56904} | |
16. | MligTC455_53333 | 44 | 0.91 | Mlig455_019019, Mlig455_055684 | Neo: - Age: Up-Down-Up Region-enriched R4: 4.725/0.03950 |
CHRNA7 | 0.972 | - | - | 0.972 | - | - | - | Mlig455_019019 {REF} {Length: 2615} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=93.9]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=210, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=207, Expect=8e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=206, Expect=3e-58]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=1e-59]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=205, Expect=3e-58]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=221, Expect=3e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=7e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=426, Expect=5e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} Mlig455_055684 {REF} {Length: 2604} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.7]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=211, Expect=9e-60]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=209, Expect=3e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=207, Expect=7e-59]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=9e-60]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=204, Expect=1e-57]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=222, Expect=1e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=6e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=427, Expect=3e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} |
17. | MligTC455_53813 | 46 | 0.96 | Mlig455_038036 | Neo: - Age: Down-Down-Up |
0.971 | - | - | 0.971 | - | - | - | Mlig455_038036 {REF} {Length: 1511} {Smed: dd_Smed_v6_12148_0_3, dd_Smed_v6_12148_0_3, [Score=70.5, Expect=9e-14]} {RNA1310_21968} {RNA815_20437} | |
18. | MligTC455_37188 | 31 | 0.65 | Mlig455_000345 | Neo: - Age: - |
TRAF5 | 0.97 | - | - | 0.970 | - | - | - | Mlig455_000345 {REF} {Length: 892} {Human: ENSG00000082512, TRAF5, TNF receptor associated factor 5, [Score=67.8, Expect=2e-12]; ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=65.5, Expect=8e-12]} {Mouse: ENSMUSG00000111385, Traf5, TNF receptor-associated factor 5, [Score=75.1, Expect=8e-16]; ENSMUSG00000026637, Traf5, TNF receptor-associated factor 5, [Score=75.1, Expect=8e-16]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=65.1, Expect=6e-12]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [Score=92.0, Expect=3e-21]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [Score=108, Expect=5e-27]} |
19. | MligTC455_21228 | 91 | 1.89 | Mlig455_010973 | Neo: - Age: - |
NOS1AP | 0.969 | - | - | 0.969 | - | - | - | Mlig455_010973 {REF} {Length: 3372} {Pfam: Phosphotyrosine interaction domain (PTB/PID) [PF00640.25, score=84.5]} {Human: ENSG00000198929, NOS1AP, nitric oxide synthase 1 adaptor protein, [RH, Score=210, Expect=2e-61]} {Mouse: ENSMUSG00000038473, Nos1ap, nitric oxide synthase 1 (neuronal) adaptor protein, [RH, Score=209, Expect=5e-61]} {Dmel: FBgn0261555, CG42673, [RH, Score=209, Expect=2e-59]} {Celegans: WBGene00001116, dyc-1, Dystrophin-like protein 1, [Score=205, Expect=2e-57]} {Smed: dd_Smed_v6_13377_0_1, dd_Smed_v6_13377_0_1, [Score=218, Expect=5e-64]} {RNA1509_56125} {RNA1310_16551, RNA1509_56125} {RNA1509_56125, RNA815_36051} |
20. | MligTC455_34948 | 28 | 0.58 | Mlig455_054519 | Neo: - Age: Up-Down-Down |
RIMS1 | 0.969 | - | - | 0.969 | - | - | - | Mlig455_054519 {REF} {Length: 5630} {Pfam: C2 domain [PF00168.32, score=104.1]; PDZ domain [PF17820.3, score=39.8]; PDZ domain [PF00595.26, score=32.1]; PDZ domain [PF13180.8, score=23.8]; Piccolo Zn-finger [PF05715.15, score=20.6]} {Human: ENSG00000079841, RIMS1, regulating synaptic membrane exocytosis 1, [RH, Score=226, Expect=2e-59]; ENSG00000176406, RIMS2, regulating synaptic membrane exocytosis 2, [RH, Score=223, Expect=1e-58]} {Mouse: ENSMUSG00000111628, Rims1, regulating synaptic membrane exocytosis 1, [RH, Score=217, Expect=8e-64]; ENSMUSG00000037386, Rims2, regulating synaptic membrane exocytosis 2, [RH, Score=217, Expect=4e-63]; ENSMUSG00000041670, Rims1, regulating synaptic membrane exocytosis 1, [RH, Score=217, Expect=8e-64]} {Dmel: FBgn0053547, Rim, Rab3 interacting molecule, [RH, Score=236, Expect=1e-62]} {Celegans: WBGene00006750, unc-10, Rab-3-interacting molecule unc-10, [RH, Score=186, Expect=2e-47]} {Smed: dd_Smed_v6_10734_0_1, dd_Smed_v6_10734_0_1, [Score=245, Expect=2e-67]} {RNA1509_26372} {RNA1310_18417} {RNA815_9566} |
21. | MligTC455_25820 | 32 | 0.67 | Mlig455_061208 | Neo: - Age: - |
0.968 | - | - | 0.968 | - | - | - | Mlig455_061208 {REF} {Length: 1262} {Celegans: WBGene00018026, F35A5.4, [Score=48.1, Expect=1e-06]} {RNA1310_123558} | |
22. | MligTC455_46452 | 134 | 2.79 | Mlig455_048151 | Neo: - Age: - Region-specific R2: 6.389 Region-enriched R2: 7.075/0.00014 Regeneration-downregulated R2: -3.162 Regeneration-depleted R2: -3.162 |
0.968 | - | - | 0.968 | - | - | - | Mlig455_048151 {REF} {Length: 618} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=25.7]} {RNA1310_62963} {RNA815_31352} | |
23. | MligTC455_06457 | 44 | 0.91 | Mlig455_058907 | Neo: - Age: Up-Down-Up |
TMEM184B | 0.967 | - | - | 0.967 | - | - | - | Mlig455_058907 {REF} {Length: 4337} {Pfam: Organic solute transporter Ostalpha [PF03619.18, score=287.2]} {Human: ENSG00000198792, TMEM184B, transmembrane protein 184B, [Score=436, Expect=3e-151]} {Mouse: ENSMUSG00000009035, Tmem184b, transmembrane protein 184b, [Score=429, Expect=1e-148]} {Dmel: FBgn0035236, CG12004, [Score=442, Expect=3e-153]} {Celegans: WBGene00009574, F40E10.6, [RH, Score=474, Expect=6e-167]} {Smed: dd_Smed_v6_3881_1_1, dd_Smed_v6_3881_1_1, [RH, Score=457, Expect=5e-161]} {RNA1310_13503.1} {RNA815_394.1} |
24. | MligTC455_19044 | 429 | 8.94 | Mlig455_000260, Mlig455_058541 | Neo: - Age: - Region-enriched R5: 2.010/0.02766 |
FAN1 | 0.967 | - | - | 0.967 | - | - | - | Mlig455_000260 {REF} {Length: 3396} {TRANSSPLICED} {Pfam: VRR-NUC domain [PF08774.13, score=64.9]} {Human: ENSG00000276787, FAN1, FANCD2 and FANCI associated nuclease 1, [RH, Score=169, Expect=1e-42]; ENSG00000198690, FAN1, FANCD2 and FANCI associated nuclease 1, [RH, Score=169, Expect=1e-42]} {Mouse: ENSMUSG00000033458, Fan1, FANCD2/FANCI-associated nuclease 1, [RH, Score=172, Expect=6e-44]} {Celegans: WBGene00015310, fan-1, Fanconi-associated nuclease 1 homolog, [RH, Score=161, Expect=8e-41]} {Smed: dd_Smed_v6_10078_0_1, dd_Smed_v6_10078_0_1, [RH, Score=116, Expect=9e-27]} {RNA1509_31937} {RNA1310_7182, RNA1509_31937} {RNA1509_31937, RNA815_30391} Mlig455_058541 {REF} {Length: 3398} {TRANSSPLICED} {Pfam: VRR-NUC domain [PF08774.13, score=65.0]} {Human: ENSG00000198690, FAN1, FANCD2 and FANCI associated nuclease 1, [RH, Score=173, Expect=8e-44]; ENSG00000276787, FAN1, FANCD2 and FANCI associated nuclease 1, [RH, Score=173, Expect=8e-44]} {Mouse: ENSMUSG00000033458, Fan1, FANCD2/FANCI-associated nuclease 1, [RH, Score=175, Expect=1e-44]} {Celegans: WBGene00015310, fan-1, Fanconi-associated nuclease 1 homolog, [RH, Score=161, Expect=1e-40]} {Smed: dd_Smed_v6_10078_0_1, dd_Smed_v6_10078_0_1, [RH, Score=112, Expect=2e-25]} {RNA1509_31937, RNA1509_37727, RNA1509_40132} {RNA1310_7182, RNA1509_37727, RNA1509_40132} {RNA1509_37727, RNA1509_40132, RNA815_30391} |
25. | MligTC455_19876 | 135 | 2.82 | Mlig455_024520, Mlig455_024523 | Neo: - Age: - |
0.967 | - | - | 0.967 | - | - | - | Mlig455_024520 {REF} {Length: 2352} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} Mlig455_024523 {REF} {Length: 2311} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=153, Expect=3e-47]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} |
|
26. | MligTC455_28723 | 57 | 1.19 | Mlig455_038771 | Neo: - Age: - |
0.967 | - | - | 0.967 | - | - | - | Mlig455_038771 {REF} {Length: 3385} {NoTransDecoderORF} {RNA1509_2485} {RNA1310_64926} {RNA815_131.1} | |
27. | MligTC455_30572 | 88 | 1.82 | Mlig455_009374, Mlig455_026650 | Neo: - Age: Down-Down-Down |
NYNRIN | 0.967 | - | - | 0.967 | - | - | - | Mlig455_009374 {REF} {Length: 592} {Pfam: RNase H-like domain found in reverse transcriptase [PF17917.3, score=104.1]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=103.6]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=57.8]; Integrase zinc binding domain [PF17921.3, score=56.9]; Integrase core domain [PF00665.28, score=46.3]; gag-polyprotein putative aspartyl protease [PF13975.8, score=22.7]} {Human: ENSG00000205978, NYNRIN, NYN domain and retroviral integrase containing, [Score=71.2, Expect=8e-12]} {Mouse: ENSMUSG00000075592, Nynrin, NYN domain and retroviral integrase containing, [Score=72.0, Expect=3e-12]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=262, Expect=3e-73]} {RNA1509_8906} {RNA1310_1712.2} {RNA815_474.1} Mlig455_026650 {REF} {Length: 3906} {Pfam: RNase H-like domain found in reverse transcriptase [PF17917.3, score=104.1]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=103.6]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=57.8]; Integrase zinc binding domain [PF17921.3, score=56.9]; Integrase core domain [PF00665.28, score=46.3]; gag-polyprotein putative aspartyl protease [PF13975.8, score=22.7]} {Human: ENSG00000205978, NYNRIN, NYN domain and retroviral integrase containing, [Score=71.2, Expect=8e-12]} {Mouse: ENSMUSG00000075592, Nynrin, NYN domain and retroviral integrase containing, [Score=72.0, Expect=3e-12]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=262, Expect=3e-73]} {RNA1509_8906} {RNA1310_1712.3} {RNA815_474.1} |
28. | MligTC455_38957 | 86 | 1.79 | Mlig455_007298 | Neo: - Age: - |
0.967 | - | - | 0.967 | - | - | - | Mlig455_007298 {REF} {Length: 2554} {Pfam: EF-hand domain [PF13405.8, score=33.1]; EF-hand domain pair [PF13499.8, score=27.9]; EF hand [PF00036.34, score=22.3]} {Mouse: ENSMUSG00000030321, Efcab12, EF-hand calcium binding domain 12, [RH, Score=66.2, Expect=1e-10]} {Smed: dd_Smed_v6_10608_0_1, dd_Smed_v6_10608_0_1, [RH, Score=54.7, Expect=1e-08]} {RNA1509_20232} {RNA1310_17116} {RNA815_14272} | |
29. | MligTC455_02244 | 25 | 0.53 | Mlig455_026007, Mlig455_070432 | Neo: - Age: - |
0.966 | - | - | 0.966 | - | - | - | Mlig455_026007 {REF} {Length: 604} {Smed: dd_Smed_v6_3944_0_1, dd_Smed_v6_3944_0_1, [Score=91.3, Expect=3e-24]} {RNA1310_143494} Mlig455_070432 {REF} {Length: 1561} {Dmel: FBgn0050419, CG30419, [RH, Score=61.6, Expect=1e-11]} {Smed: dd_Smed_v6_3944_0_1, dd_Smed_v6_3944_0_1, [RH, Score=112, Expect=2e-32]} {RNA1310_143494} |
|
30. | MligTC455_16672 | 41 | 0.86 | Mlig455_019194 | Neo: - Age: - Region-enriched R2: 5.301/0.02053 |
0.966 | - | - | 0.966 | - | - | - | Mlig455_019194 {REF} {Length: 648} {RNA1310_52751} {RNA815_26203} | |
31. | MligTC455_19187 | 156 | 3.26 | Mlig455_018418 | Neo: - Age: - Region-enriched R2: 2.105/0.03594 |
NRXN1 | 0.966 | - | - | 0.966 | - | - | - | Mlig455_018418 {REF} {Length: 6075} {Pfam: Laminin G domain [PF02210.26, score=290.6]; Laminin G domain [PF00054.25, score=213.6]; Syndecan domain [PF01034.22, score=25.6]; EGF-like domain [PF00008.29, score=22.7]} {Human: ENSG00000179915, NRXN1, neurexin 1, [RH, Score=396, Expect=2e-114]} {Mouse: ENSMUSG00000024109, Nrxn1, neurexin I, [Score=408, Expect=3e-119]} {Dmel: FBgn0038975, Nrx-1, Neurexin 1, [Score=315, Expect=2e-87]} {Celegans: WBGene00007799, nrx-1, NRX-1 beta isoform; NeuReXin related, [Score=119, Expect=9e-27]} {Smed: dd_Smed_v6_13697_0_1, dd_Smed_v6_13697_0_1, [RH, Score=429, Expect=2e-128]} {RNA1509_34878} {RNA1310_1222.1} {RNA815_16735} |
32. | MligTC455_30131 | 21 | 0.44 | Mlig455_070322 | Neo: - Age: Up-Down-Up |
0.966 | - | - | 0.966 | - | - | - | Mlig455_070322 {REF} {Length: 3157} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=33.9]} {Dmel: FBgn0034168, CG15614, [Score=57.4, Expect=2e-08]} {Smed: dd_Smed_v6_11997_0_1, dd_Smed_v6_11997_0_1, [RH, Score=150, Expect=3e-40]} {RNA1310_84484} {RNA815_49731} | |
33. | MligTC455_45666 | 652 | 13.58 | Mlig455_013011, Mlig455_013040 | Neo: - Age: Up-Down-Up Region-specific R2: 4.509 Region-enriched R2: 3.140/0.01108 |
0.966 | - | - | 0.966 | - | - | - | Mlig455_013011 {REF} {Length: 1193} {RNA1509_13068} {RNA1310_46610} {RNA815_23273} Mlig455_013040 {REF} {Length: 923} {RNA1509_13068} {RNA1310_46610, RNA1509_13068} {RNA1509_13068, RNA815_23273} |
|
34. | MligTC455_30463 | 95 | 1.98 | Mlig455_000250, Mlig455_058521, Mlig455_058532 | Neo: - Age: - |
0.965 | - | - | 0.965 | - | - | - | Mlig455_000250 {REF} {Length: 1994} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.7]} {RNA1310_59451} {RNA815_40085} Mlig455_058521 {REF} {Length: 1237} {RNA1310_56656} {RNA815_40085} Mlig455_058532 {REF} {Length: 1973} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.5]} {RNA1310_59451} {RNA815_40085} |
|
35. | MligTC455_44955 | 757 | 15.78 | Mlig455_029614 | Neo: Int S/G2/M Age: - Region-specific R2: 8.255 Region-enriched R2: 9.875/0.00000 |
0.965 | - | - | 0.965 | - | - | - | Mlig455_029614 {REF} {Length: 499} {Pfam: Pancreatic hormone peptide [PF00159.20, score=31.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.8, Expect=9e-09]} {RNA1509_17163} {RNA1310_66833.1, RNA1509_17163} {RNA1509_17163, RNA815_41767} | |
36. | MligTC455_45085 | 848 | 17.67 | Mlig455_019350, Mlig455_019569, Mlig455_059128 | Neo: - Age: - Region-enriched R2: 3.751/0.00011 |
0.965 | - | - | 0.965 | - | - | - | Mlig455_019350 {REF} {Length: 2183} {Pfam: Thrombospondin type 1 domain [PF19030.2, score=27.8]} {RNA1509_40461} {RNA1310_18714.1, RNA1509_40461} {RNA1509_40461, RNA815_7309} Mlig455_019569 {REF} {Length: 2135} {Pfam: Thrombospondin type 1 domain [PF19030.2, score=27.9]} {RNA1509_40461} {RNA1310_18714.1} {RNA815_7309} Mlig455_059128 {REF} {Length: 2080} {Pfam: Thrombospondin type 1 domain [PF19030.2, score=27.9]} {RNA1509_40461} {RNA1310_18714.1} {RNA815_7309} |
|
37. | MligTC455_29315 | 105 | 2.19 | Mlig455_041530, Mlig455_069393 | Neo: - Age: logFC(26M/2M)=1.756 |
0.964 | - | - | 0.964 | - | - | - | Mlig455_041530 {REF} {Length: 2302} {RNA1310_27036} {RNA815_28595} Mlig455_069393 {REF} {Length: 1213} {RNA1310_27036} {RNA815_28595} |
|
38. | MligTC455_35813 | 35 | 0.73 | Mlig455_013562, Mlig455_013615 | Neo: - Age: - Region-enriched R2: 7.733/0.00085 |
NPR2 | 0.964 | - | - | 0.964 | - | - | - | Mlig455_013562 {REF} {Length: 3105} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.6]; Nitrate and nitrite sensing [PF08376.12, score=108.9]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=247, Expect=6e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=1e-73]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=248, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=330, Expect=3e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=7e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_27869} Mlig455_013615 {REF} {Length: 2993} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.7]; Nitrate and nitrite sensing [PF08376.12, score=109.5]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=246, Expect=8e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=9e-74]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=247, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=331, Expect=1e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=8e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_33407} |
39. | MligTC455_36066 | 190 | 3.96 | Mlig455_055150 | Neo: - Age: - |
0.964 | - | - | 0.964 | - | - | - | Mlig455_055150 {REF} {Length: 4368} {TRANSSPLICED} {RNA1509_38168} {RNA1310_732.1, RNA1509_38168} {RNA1509_38168, RNA815_9144} | |
40. | MligTC455_40781 | 153 | 3.2 | Mlig455_024109, Mlig455_063982 | Neo: - Age: - |
0.964 | - | - | 0.964 | - | - | - | Mlig455_024109 {REF} {Length: 1081} {RNA1509_16458} {RNA1310_43664.1, RNA1509_16458} {RNA1509_16458, RNA815_23166} Mlig455_063982 {REF} {Length: 3562} {RNA1509_16458} {RNA1310_30070} {RNA815_23166} |
|
41. | MligTC455_44328 | 858 | 17.88 | Mlig455_026172 | Neo: - Age: Down-Up-Up Region-specific R2: 4.714 Region-enriched R2: 4.385/0.00000 |
0.964 | - | - | 0.964 | - | - | - | Mlig455_026172 {REF} {Length: 661} {RNA1509_32102, RNA1509_34635} {RNA1310_60068, RNA1509_32102, RNA1509_34635} {RNA1509_32102, RNA1509_34635, RNA815_37486} | |
42. | MligTC455_03696 | 75 | 1.57 | Mlig455_007008 | Neo: - Age: - |
CACNA1H | 0.963 | - | - | 0.963 | - | - | - | Mlig455_007008 {REF} {Length: 6530} {Pfam: Ion transport protein [PF00520.33, score=430.6]; Polycystin cation channel [PF08016.14, score=56.2]} {Human: ENSG00000196557, CACNA1H, calcium voltage-gated channel subunit alpha1 H, [Score=836, Expect=0.0]} {Mouse: ENSMUSG00000024112, Cacna1h, calcium channel, voltage-dependent, T type, alpha 1H subunit, [Score=838, Expect=0.0]} {Dmel: FBgn0264386, Ca-alpha1T, Ca[2+]-channel protein alpha[[1]] subunit T, [RH, Score=857, Expect=0.0]} {Celegans: WBGene00000367, cca-1, Voltage-dependent T-type calcium channel subunit alpha, [RH, Score=761, Expect=0.0]} {Smed: dd_Smed_v6_16822_0_1, dd_Smed_v6_16822_0_1, [RH, Score=916, Expect=0.0]} {RNA1509_28376} {RNA1310_9083} {RNA815_21869} |
43. | MligTC455_19412 | 42 | 0.88 | Mlig455_047997 | Neo: - Age: - |
0.963 | - | - | 0.963 | - | - | - | Mlig455_047997 {REF} {Length: 701} {RNA1310_53549} {RNA815_27051} | |
44. | MligTC455_25800 | 19 | 0.39 | Mlig455_020935 | Neo: - Age: - |
0.963 | - | - | 0.963 | - | - | - | Mlig455_020935 {REF} {Length: 1333} {Smed: dd_Smed_v6_91651_0_1, dd_Smed_v6_91651_0_1, [RH, Score=54.7, Expect=7e-10]} {RNA1509_46103} {RNA1310_6410.1} {RNA815_31889} | |
45. | MligTC455_29543 | 94 | 1.96 | Mlig455_066835 | Neo: - Age: Down-Down-Up Region-enriched R2: 3.991/0.02759 |
PGBD4 | 0.963 | - | - | 0.963 | - | - | - | Mlig455_066835 {REF} {Length: 7088} {Pfam: Transposase IS4 [PF13843.8, score=213.7]} {Human: ENSG00000182405, PGBD4, piggyBac transposable element derived 4, [RH, Score=206, Expect=4e-59]} {Mouse: ENSMUSG00000050751, Pgbd5, piggyBac transposable element derived 5, [RH, Score=74.3, Expect=1e-13]} {Dmel: FBgn0037633, CG9839, [RH, Score=96.3, Expect=7e-21]} {Smed: dd_Smed_v6_48522_0_1, dd_Smed_v6_48522_0_1, [RH, Score=116, Expect=1e-29]} {RNA1509_18157} {RNA1310_616.1} {RNA815_9301.1} |
46. | MligTC455_33463 | 240 | 4.99 | Mlig455_023684 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.110/0.00054 |
PKD1L2 | 0.963 | - | - | 0.963 | - | - | - | Mlig455_023684 {REF} {Length: 12137} {Pfam: Polycystin cation channel [PF08016.14, score=271.5]; PKD domain [PF00801.22, score=88.3]; PLAT/LH2 domain [PF01477.25, score=72.6]; PKD domain [PF18911.2, score=49.9]; Ion transport protein [PF00520.33, score=46.0]; F5/8 type C domain [PF00754.27, score=33.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [RH, Score=263, Expect=2e-69]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=272, Expect=3e-72]} {Dmel: FBgn0050048, CG30048, [Score=57.4, Expect=3e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=144, Expect=2e-33]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=518, Expect=3e-147]} {RNA1509_5488} {RNA1310_100} {RNA815_3211} |
47. | MligTC455_33832 | 112 | 2.34 | Mlig455_029411 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.300/0.00016 |
GLRA3 | 0.963 | - | - | 0.963 | - | - | - | Mlig455_029411 {REF} {Length: 3686} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.5]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=257, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=253, Expect=3e-78]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=250, Expect=4e-77]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=251, Expect=2e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=5e-77]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=2e-76]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=243, Expect=1e-74]} {Dmel: FBgn0024963, GluClalpha, [Score=253, Expect=2e-78]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=259, Expect=7e-81]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=480, Expect=1e-167]} {RNA1509_35986} {RNA1310_35528} {RNA815_35433} |
48. | MligTC455_37058 | 19 | 0.4 | Mlig455_061075 | Neo: - Age: - |
0.963 | - | - | 0.963 | - | - | - | Mlig455_061075 {REF} {Length: 4598} {Pfam: IQ calmodulin-binding motif [PF00612.29, score=31.8]} {RNA1509_56135} {RNA1310_6435} {RNA815_17633} | |
49. | MligTC455_38217 | 71 | 1.48 | Mlig455_038564, Mlig455_052193, Mlig455_053460 | Neo: - Age: - |
0.962 | - | - | 0.962 | - | - | - | Mlig455_038564 {REF} {Length: 474} {NoTransDecoderORF} {RNA1509_54683} {RNA1310_22137} {RNA815_61625} Mlig455_052193 {REF} {Length: 428} {NoTransDecoderORF} {RNA1509_54683} {RNA1310_22137} {RNA815_61625} Mlig455_053460 {REF} {Length: 474} {NoTransDecoderORF} {RNA1509_54683} {RNA1310_22137} {RNA815_61625} |
|
50. | MligTC455_00282 | 64 | 1.34 | Mlig455_011958 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_011958 {REF} {Length: 258} {NoTransDecoderORF} | |
51. | MligTC455_02553 | 40 | 0.83 | Mlig455_057382, Mlig455_057405 | Neo: - Age: Up-Down-Up Region-enriched R2: 4.891/0.03381 |
0.961 | - | - | 0.961 | - | - | - | Mlig455_057382 {REF} {Length: 445} {NoTransDecoderORF} {RNA1310_52629} Mlig455_057405 {REF} {Length: 4885} {TRANSSPLICED} {Celegans: WBGene00012980, efhd-1, EF HanD calcium binding protein, [Score=46.2, Expect=8e-06]} {RNA1310_42652} {RNA815_37610} |
|
52. | MligTC455_04269 | 11 | 0.23 | Mlig455_060972 | Neo: - Age: - |
HRH3 | 0.961 | - | - | 0.961 | - | - | - | Mlig455_060972 {REF} {Length: 2387} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=109.1]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=31.8]; Olfactory receptor [PF13853.8, score=28.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=27.1]; Domain of unknown function (DUF3413) [PF11893.10, score=22.0]} {Human: ENSG00000101180, HRH3, histamine receptor H3, [Score=77.8, Expect=4e-15]; ENSG00000113749, HRH2, histamine receptor H2, [Score=76.6, Expect=1e-14]} {Mouse: ENSMUSG00000034987, Hrh2, histamine receptor H2, [Score=77.4, Expect=5e-15]} {Dmel: FBgn0000037, mAChR-A, muscarinic Acetylcholine Receptor, A-type, [Score=71.2, Expect=6e-13]} {Celegans: WBGene00001519, gar-3, Muscarinic acetylcholine receptor gar-3, [Score=72.4, Expect=2e-13]} {Smed: dd_Smed_v6_20043_0_1, dd_Smed_v6_20043_0_1, [Score=71.2, Expect=3e-13]} {RNA1310_60530.2} {RNA815_47633} |
53. | MligTC455_06200 | 8 | 0.17 | Mlig455_022367 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_022367 {REF} {Length: 738} {Pfam: WSC domain [PF01822.21, score=44.0]; PAN domain [PF00024.28, score=20.8]} {RNA1310_89673} {RNA815_64813} | |
54. | MligTC455_06448 | 13 | 0.26 | Mlig455_022314, Mlig455_069882 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_022314 {REF} {Length: 354} {Pfam: Pancreatic hormone peptide [PF00159.20, score=26.8]} {RNA1310_54016} {RNA815_51613} Mlig455_069882 {REF} {Length: 365} {Pfam: Pancreatic hormone peptide [PF00159.20, score=29.8]} {RNA1310_54016} {RNA815_51613} |
|
55. | MligTC455_08518 | 6 | 0.12 | Mlig455_011791 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_011791 {REF} {Length: 905} {Pfam: Lectin C-type domain [PF00059.23, score=27.5]} {Mouse: ENSMUSG00000008874, Clec3a, C-type lectin domain family 3, member a, [Score=46.6, Expect=6e-06]} {RNA1509_20946} {RNA1310_57972} {RNA815_39424} | |
56. | MligTC455_08774 | 25 | 0.53 | Mlig455_001889 | Neo: - Age: Up-Down-Down |
HCRTR2 | 0.961 | - | - | 0.961 | - | - | - | Mlig455_001889 {REF} {Length: 3436} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=160.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=30.4]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=24.1]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=215, Expect=2e-63]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [RH, Score=212, Expect=1e-62]} {Dmel: FBgn0038874, ETHR, [Score=142, Expect=6e-37]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=116, Expect=6e-28]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=202, Expect=1e-59]} {RNA1310_31833} {RNA815_15909} |
57. | MligTC455_09758 | 74 | 1.55 | Mlig455_022290 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_022290 {REF} {Length: 1401} {RNA1509_44223} {RNA1310_54802} {RNA815_22126} | |
58. | MligTC455_09877 | 4 | 0.08 | Mlig455_062683 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_062683 {REF} {Length: 2060} {RNA1310_74180.2} {RNA815_61774} | |
59. | MligTC455_13123 | 6 | 0.12 | Mlig455_061115 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_061115 {REF} {Length: 2302} {Pfam: PAN domain [PF00024.28, score=19.6]} {RNA1509_16100} {RNA1310_39798} {RNA815_59357} | |
60. | MligTC455_13545 | 8 | 0.17 | Mlig455_053118 | Neo: - Age: - |
ZAN | 0.961 | - | - | 0.961 | - | - | - | Mlig455_053118 {REF} {Length: 2962} {Pfam: Glycine rich protein [PF12810.9, score=18.9]} {Human: ENSG00000146839, ZAN, zonadhesin (gene/pseudogene), [Score=69.7, Expect=1e-11]} {Dmel: FBgn0052834, CG32834, [Score=66.6, Expect=4e-11]} {Celegans: WBGene00004996, spp-11, Saposin-like protein 11, [Score=50.4, Expect=3e-06]} {RNA1310_57796.1} {RNA815_27813} |
61. | MligTC455_17266 | 62 | 1.3 | Mlig455_043650 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_043650 {REF} {Length: 2826} {RNA1310_48878} {RNA815_25527} | |
62. | MligTC455_18319 | 68 | 1.42 | Mlig455_033078 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_033078 {REF} {Length: 3408} {Pfam: Leucine rich repeat [PF13855.8, score=25.1]} {RNA1509_58507} {RNA1310_56511} {RNA815_53024} | |
63. | MligTC455_19232 | 31 | 0.65 | Mlig455_059817, Mlig455_061500 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_059817 {REF} {Length: 1369} {RNA1310_23693} {RNA815_52682} Mlig455_061500 {REF} {Length: 1202} {RNA1310_23693} {RNA815_52682} |
|
64. | MligTC455_19546 | 18 | 0.37 | Mlig455_053800 | Neo: - Age: - |
CUBN | 0.961 | - | - | 0.961 | - | - | - | Mlig455_053800 {REF} {Length: 3139} {Pfam: CUB domain [PF00431.22, score=96.2]} {Human: ENSG00000107611, CUBN, cubilin, [Score=65.5, Expect=3e-10]} {Mouse: ENSMUSG00000026726, Cubn, cubilin (intrinsic factor-cobalamin receptor), [Score=65.1, Expect=3e-10]} {Dmel: FBgn0261262, CG42613, [Score=93.2, Expect=2e-19]} {Celegans: WBGene00010587, sol-2, SOL-2 protein; Suppressor Of Lurcher movement defect, [Score=106, Expect=3e-24]} {Smed: dd_Smed_v6_11447_0_1, dd_Smed_v6_11447_0_1, [Score=73.6, Expect=2e-13]} {RNA1310_54691} |
65. | MligTC455_21608 | 9 | 0.18 | Mlig455_011723 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_011723 {REF} {Length: 501} {NoTransDecoderORF} {RNA1509_38266} {RNA1310_19274} {RNA815_45710} | |
66. | MligTC455_28719 | 17 | 0.36 | Mlig455_029838 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_029838 {REF} {Length: 2181} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=140.7]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=48.5, Expect=9e-06]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [Score=90.1, Expect=4e-19]} {RNA1310_71846} {RNA815_38264} | |
67. | MligTC455_29339 | 176 | 3.67 | Mlig455_018221, Mlig455_036131 | Neo: Irradiation Age: Up-Down-Down |
CNBP | 0.961 | - | - | 0.961 | - | - | - | Mlig455_018221 {REF} {Length: 5982} {Pfam: Zinc knuckle [PF00098.25, score=25.6]} {RNA1509_21798} {RNA1310_927.1} {RNA815_827} Mlig455_036131 {REF} {Length: 4130} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=54.5]; gag-polyprotein putative aspartyl protease [PF13975.8, score=33.3]; Aspartyl protease [PF13650.8, score=23.3]; Zinc knuckle [PF00098.25, score=23.1]} {Human: ENSG00000169714, CNBP, CCHC-type zinc finger nucleic acid binding protein, [Score=50.1, Expect=2e-06]} {Mouse: ENSMUSG00000030057, Cnbp, cellular nucleic acid binding protein, [Score=50.1, Expect=1e-06]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=112, Expect=1e-25]} {RNA1509_21798} {RNA1310_927.1} {RNA815_827} |
68. | MligTC455_30166 | 5 | 0.1 | Mlig455_066878 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_066878 {REF} {Length: 1273} {Pfam: F5/8 type C domain [PF00754.27, score=44.4]} {Dmel: FBgn0001083, fw, furrowed, [Score=56.6, Expect=6e-09]} {RNA1509_18097} {RNA1310_40485.2} {RNA815_23721} | |
69. | MligTC455_32292 | 66 | 1.38 | Mlig455_028882 | Neo: - Age: - Region-enriched R2: 3.876/0.02790 |
GRIK2 | 0.961 | - | - | 0.961 | - | - | - | Mlig455_028882 {REF} {Length: 3574} {Pfam: Ligand-gated ion channel [PF00060.28, score=188.3]; Receptor family ligand binding region [PF01094.30, score=116.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=103.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=84.0]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=609, Expect=0.0]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=585, Expect=0.0]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=583, Expect=0.0]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=609, Expect=0.0]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=581, Expect=0.0]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=580, Expect=0.0]} {Dmel: FBgn0039927, CG11155, [RH, Score=615, Expect=0.0]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=412, Expect=4e-129]} {Smed: dd_Smed_v6_8816_0_1, dd_Smed_v6_8816_0_1, [Score=471, Expect=1e-149]} {RNA1509_15645} {RNA1310_1989.1, RNA1509_15645} {RNA1509_15645, RNA815_797} |
70. | MligTC455_33130 | 12 | 0.25 | Mlig455_070332 | Neo: - Age: - |
NPFFR2 | 0.961 | - | - | 0.961 | - | - | - | Mlig455_070332 {REF} {Length: 2904} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=133.1]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=24.8]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=122, Expect=6e-30]; ENSG00000075073, TACR2, tachykinin receptor 2, [Score=122, Expect=7e-30]} {Mouse: ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=130, Expect=8e-33]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=127, Expect=2e-31]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=134, Expect=2e-34]} {Smed: dd_Smed_v6_17752_0_1, dd_Smed_v6_17752_0_1, [Score=207, Expect=3e-61]} {RNA1310_49566} {RNA815_29712} |
71. | MligTC455_34949 | 30 | 0.63 | Mlig455_055437 | Neo: - Age: - |
RIMS1 | 0.961 | - | - | 0.961 | - | - | - | Mlig455_055437 {REF} {Length: 5246} {Pfam: C2 domain [PF00168.32, score=104.4]; PDZ domain [PF17820.3, score=39.9]; PDZ domain [PF00595.26, score=32.1]; Piccolo Zn-finger [PF05715.15, score=24.7]; PDZ domain [PF13180.8, score=24.0]; FYVE-type zinc finger [PF02318.18, score=19.4]} {Human: ENSG00000079841, RIMS1, regulating synaptic membrane exocytosis 1, [RH, Score=239, Expect=2e-63]; ENSG00000176406, RIMS2, regulating synaptic membrane exocytosis 2, [RH, Score=238, Expect=2e-63]} {Mouse: ENSMUSG00000037386, Rims2, regulating synaptic membrane exocytosis 2, [RH, Score=241, Expect=3e-64]; ENSMUSG00000111628, Rims1, regulating synaptic membrane exocytosis 1, [RH, Score=240, Expect=1e-66]; ENSMUSG00000041670, Rims1, regulating synaptic membrane exocytosis 1, [RH, Score=240, Expect=1e-66]} {Dmel: FBgn0053547, Rim, Rab3 interacting molecule, [RH, Score=243, Expect=6e-65]} {Celegans: WBGene00006750, unc-10, Rab-3-interacting molecule unc-10, [RH, Score=187, Expect=1e-47]} {Smed: dd_Smed_v6_10734_0_1, dd_Smed_v6_10734_0_1, [RH, Score=281, Expect=6e-80]} {RNA1509_26372} {RNA1310_18417, RNA1509_26372} {RNA1509_26372, RNA815_9566} |
72. | MligTC455_36193 | 13 | 0.27 | Mlig455_025794 | Neo: - Age: - |
B3GNT4 | 0.961 | - | - | 0.961 | - | - | - | Mlig455_025794 {REF} {Length: 3112} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=1e-20]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.0, Expect=2e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.2, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.2, Expect=3e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=91.7, Expect=1e-19]} {Dmel: FBgn0031988, CG8668, [Score=89.7, Expect=1e-18]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} |
73. | MligTC455_37701 | 47 | 0.98 | Mlig455_029831 | Neo: - Age: - Region-enriched R2: 8.298/0.02665 |
0.961 | - | - | 0.961 | - | - | - | Mlig455_029831 {REF} {Length: 724} {RNA1310_73844} | |
74. | MligTC455_41315 | 18 | 0.38 | Mlig455_050678 | Neo: - Age: - |
GALR2 | 0.961 | - | - | 0.961 | - | - | - | Mlig455_050678 {REF} {Length: 1712} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=85.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=32.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.4]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=63.2, Expect=3e-10]} {Mouse: ENSMUSG00000024798, Htr7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=63.5, Expect=1e-10]; ENSMUSG00000037393, Nmur2, neuromedin U receptor 2, [Score=60.8, Expect=9e-10]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [Score=57.4, Expect=1e-08]} {Celegans: WBGene00018728, frpr-8, FMRFamide Peptide Receptor family, [Score=50.4, Expect=1e-06]} {Smed: dd_Smed_v6_14726_0_1, dd_Smed_v6_14726_0_1, [Score=102, Expect=5e-24]} {RNA1509_29633} {RNA1310_16447, RNA1509_29633} {RNA1509_29633, RNA815_8324} |
75. | MligTC455_43115 | 12 | 0.25 | Mlig455_011719 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_011719 {REF} {Length: 1831} {RNA1310_81493} {RNA815_42582} | |
76. | MligTC455_47248 | 12 | 0.24 | Mlig455_024212 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_024212 {REF} {Length: 1646} {Smed: dd_Smed_v6_14508_0_1, dd_Smed_v6_14508_0_1, [RH, Score=75.5, Expect=2e-16]} {RNA1310_72968} {RNA815_46883} | |
77. | MligTC455_49077 | 11 | 0.22 | Mlig455_028465 | Neo: - Age: - |
SCNN1B | 0.961 | - | - | 0.961 | - | - | - | Mlig455_028465 {REF} {Length: 1973} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=191.1]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=75.9, Expect=9e-14]} {Mouse: ENSMUSG00000038276, Asic3, acid-sensing (proton-gated) ion channel 3, [Score=65.9, Expect=6e-11]; ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [Score=62.8, Expect=7e-10]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=70.1, Expect=2e-12]} {Smed: dd_Smed_v6_26855_0_1, dd_Smed_v6_26855_0_1, [Score=260, Expect=5e-79]} {RNA1310_116633} |
78. | MligTC455_49396 | 157 | 3.27 | Mlig455_018614 | Neo: - Age: - |
TNN | 0.961 | - | - | 0.961 | - | - | - | Mlig455_018614 {REF} {Length: 1533} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=113.4]} {Human: ENSG00000120332, TNN, tenascin N, [Score=107, Expect=2e-25]} {Mouse: ENSMUSG00000026725, Tnn, tenascin N, [Score=108, Expect=3e-26]} {Dmel: FBgn0050280, CG30280, [Score=95.9, Expect=4e-23]} {Celegans: WBGene00020516, T15B7.1, [Score=60.5, Expect=2e-10]} {RNA1310_79803} {RNA815_40596} |
79. | MligTC455_51090 | 20 | 0.42 | Mlig455_019411 | Neo: - Age: - |
TTN | 0.961 | - | - | 0.961 | - | - | - | Mlig455_019411 {REF} {Length: 2557} {Pfam: Immunoglobulin domain [PF13927.8, score=55.3]; Immunoglobulin I-set domain [PF07679.18, score=54.2]; Immunoglobulin domain [PF00047.27, score=42.6]; Immunoglobulin domain [PF13895.8, score=41.5]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=23.2]} {Human: ENSG00000155657, TTN, titin, [Score=57.4, Expect=7e-08]; ENSG00000163531, NFASC, neurofascin, [Score=56.6, Expect=6e-08]; ENSG00000174498, IGDCC3, immunoglobulin superfamily DCC subclass member 3, [Score=55.1, Expect=2e-07]} {Mouse: ENSMUSG00000051747, Ttn, titin, [Score=56.6, Expect=8e-08]; ENSMUSG00000026442, Nfasc, neurofascin, [Score=56.2, Expect=8e-08]; ENSMUSG00000061751, Kalrn, kalirin, RhoGEF kinase, [Score=55.5, Expect=1e-07]; ENSMUSG00000032394, Igdcc3, immunoglobulin superfamily, DCC subclass, member 3, [Score=53.9, Expect=3e-07]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=57.8, Expect=2e-08]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=50.4, Expect=3e-06]} {Smed: dd_Smed_v6_15129_0_2, dd_Smed_v6_15129_0_2, [RH, Score=97.4, Expect=8e-22]} {RNA1509_60115} {RNA1310_47926.1} {RNA815_39809} |
80. | MligTC455_10947 | 15 | 0.31 | Mlig455_050032 | Neo: - Age: - |
0.96 | - | - | 0.960 | - | - | - | Mlig455_050032 {REF} {Length: 309} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_46344} {RNA1310_4333.2} {RNA815_13389} | |
81. | MligTC455_12130 | 17 | 0.34 | Mlig455_013783 | Neo: - Age: - |
0.96 | - | - | 0.960 | - | - | - | Mlig455_013783 {REF} {Length: 1520} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=40.5]} {Smed: dd_Smed_v6_33525_0_1, dd_Smed_v6_33525_0_1, [Score=115, Expect=3e-30]} {RNA1310_68929} {RNA815_54261} | |
82. | MligTC455_12700 | 10 | 0.22 | Mlig455_010549 | Neo: - Age: - |
0.96 | - | - | 0.960 | - | - | - | Mlig455_010549 {REF} {Length: 849} {Pfam: F5/8 type C domain [PF00754.27, score=28.5]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=54.3, Expect=2e-09]} {RNA1509_36923} {RNA1310_38503} {RNA815_10591.3} | |
83. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
0.96 | - | - | 0.960 | - | - | - | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
84. | MligTC455_24108 | 17 | 0.35 | Mlig455_019116 | Neo: - Age: - |
KCNK16 | 0.96 | - | - | 0.960 | - | - | - | Mlig455_019116 {REF} {Length: 1389} {Pfam: Ion channel [PF07885.18, score=118.0]; Ion transport protein [PF00520.33, score=29.1]} {Human: ENSG00000095981, KCNK16, potassium two pore domain channel subfamily K member 16, [Score=155, Expect=5e-44]} {Mouse: ENSMUSG00000023243, Kcnk5, potassium channel, subfamily K, member 5, [RH, Score=141, Expect=3e-37]} {Dmel: FBgn0037690, Task7, TWIK-related acid-sensitive K[+] channel 7, [Score=110, Expect=3e-27]} {Celegans: WBGene00006696, twk-46, TWiK family of potassium channels, [Score=115, Expect=3e-29]} {Smed: dd_Smed_v6_9028_0_1, dd_Smed_v6_9028_0_1, [Score=121, Expect=4e-31]} {RNA1310_125949} |
85. | MligTC455_24218 | 6 | 0.12 | Mlig455_039181 | Neo: - Age: - |
NMUR2 | 0.96 | - | - | 0.960 | - | - | - | Mlig455_039181 {REF} {Length: 2177} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=151.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=42.6]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=22.1]} {Human: ENSG00000132911, NMUR2, neuromedin U receptor 2, [RH, Score=174, Expect=3e-48]} {Mouse: ENSMUSG00000037393, Nmur2, neuromedin U receptor 2, [RH, Score=186, Expect=3e-53]} {Dmel: FBgn0038139, PK2-R2, Pyrokinin 2 receptor 2, [RH, Score=203, Expect=8e-58]} {Celegans: WBGene00019616, nmur-2, NMUR (NeuroMedin U Receptor) homolog, [RH, Score=196, Expect=4e-57]} {Smed: dd_Smed_v6_27499_0_1, dd_Smed_v6_27499_0_1, [RH, Score=258, Expect=4e-79]} {RNA1310_31955.1} {RNA815_40657} |
86. | MligTC455_29586 | 237 | 4.95 | Mlig455_024687, Mlig455_024712 | Neo: - Age: - Region-specific R2: 5.384 Region-enriched R2: 6.584/0.00000 |
0.96 | - | - | 0.960 | - | - | - | Mlig455_024687 {REF} {Length: 1636} {RNA1509_26262} {RNA1310_30838} {RNA815_35621} Mlig455_024712 {REF} {Length: 1612} {RNA1509_26262} {RNA1310_30838} {RNA815_35621} |
|
87. | MligTC455_40354 | 8 | 0.16 | Mlig455_038072 | Neo: - Age: - |
0.96 | - | - | 0.960 | - | - | - | Mlig455_038072 {REF} {Length: 545} {Pfam: PAN domain [PF00024.28, score=24.5]; MANEC domain [PF07502.16, score=21.0]} {RNA1509_46267} {RNA1310_46146} {RNA815_42573} | |
88. | MligTC455_52076 | 203 | 4.23 | Mlig455_066929 | Neo: - Age: - |
NXF1 | 0.96 | - | - | 0.960 | - | - | - | Mlig455_066929 {REF} {Length: 3005} {Pfam: TAP C-terminal domain [PF03943.15, score=70.6]; Tap, RNA-binding [PF09162.12, score=66.9]} {Human: ENSG00000162231, NXF1, nuclear RNA export factor 1, [Score=186, Expect=1e-50]; ENSG00000269437, NXF2B, nuclear RNA export factor 2B, [Score=185, Expect=3e-50]; ENSG00000269405, NXF2, nuclear RNA export factor 2, [Score=185, Expect=3e-50]} {Mouse: ENSMUSG00000010097, Nxf1, nuclear RNA export factor 1, [Score=186, Expect=1e-50]} {Dmel: FBgn0003321, sbr, small bristles, [Score=134, Expect=8e-33]} {Celegans: WBGene00003834, nxf-1, Nuclear RNA export factor 1, [Score=98.6, Expect=2e-21]} {Smed: dd_Smed_v6_6082_0_1, dd_Smed_v6_6082_0_1, [Score=63.9, Expect=1e-10]} {RNA1509_6988} {RNA1310_4213} {RNA815_4098.1} |
89. | MligTC455_54282 | 74 | 1.54 | Mlig455_020191 | Neo: - Age: - |
0.96 | - | - | 0.960 | - | - | - | Mlig455_020191 {REF} {Length: 937} {RNA1509_48973} {RNA1310_40738.2} {RNA815_31898} | |
90. | MligTC455_55515 | 10 | 0.2 | Mlig455_038073 | Neo: - Age: - |
WSCD2 | 0.96 | - | - | 0.960 | - | - | - | Mlig455_038073 {REF} {Length: 370} {Pfam: WSC domain [PF01822.21, score=58.4]; PAN domain [PF00024.28, score=25.1]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=62.0, Expect=3e-10]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=52.0, Expect=3e-07]; ENSMUSG00000020811, Wscd1, WSC domain containing 1, [Score=50.4, Expect=1e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=47.0, Expect=1e-05]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=47.4, Expect=8e-06]} {RNA1509_46267} {RNA1310_46146} {RNA815_32275.1} |
91. | MligTC455_14856 | 14 | 0.29 | Mlig455_023184 | Neo: - Age: - |
ANGPTL7 | 0.959 | - | - | 0.959 | - | - | - | Mlig455_023184 {REF} {Length: 1290} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.4]; PAN domain [PF00024.28, score=23.8]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=1e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=3e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=104, Expect=1e-25]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=102, Expect=4e-24]} {Dmel: FBgn0033312, CG8642, [Score=96.7, Expect=2e-22]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=98.6, Expect=5e-23]} {RNA1509_58115} {RNA1310_36699.1} {RNA815_17918.1} |
92. | MligTC455_19851 | 20 | 0.42 | Mlig455_065944, Mlig455_065961 | Neo: - Age: - |
GUCY1B1, NPR2 | 0.959 | - | - | 0.959 | - | - | - | Mlig455_065944 {REF} {Length: 1047} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=68.0]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=80.5, Expect=8e-18]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=78.6, Expect=3e-17]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=77.4, Expect=7e-17]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=80.9, Expect=4e-18]; ENSMUSG00000021933, Gucy1b2, guanylate cyclase 1, soluble, beta 2, [Score=78.6, Expect=2e-17]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=77.0, Expect=7e-17]} {Dmel: FBgn0038295, Gyc88E, Guanylyl cyclase at 88E, [Score=93.2, Expect=1e-22]} {Celegans: WBGene00001539, gcy-13, Receptor-type guanylate cyclase gcy-13, [Score=77.4, Expect=3e-17]} {Smed: dd_Smed_v6_18111_0_1, dd_Smed_v6_18111_0_1, [Score=114, Expect=3e-30]} {RNA1509_55074} {RNA1310_24262} {RNA815_31087} Mlig455_065961 {REF} {Length: 2796} {Pfam: Heme NO binding associated [PF07701.16, score=218.0]; Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=199.9]; Haem-NO-binding [PF07700.17, score=175.1]} {Human: ENSG00000061918, GUCY1B1, guanylate cyclase 1 soluble subunit beta 1, [Score=338, Expect=3e-107]} {Mouse: ENSMUSG00000028005, Gucy1b1, guanylate cyclase 1, soluble, beta 1, [Score=342, Expect=5e-109]; ENSMUSG00000021933, Gucy1b2, guanylate cyclase 1, soluble, beta 2, [Score=339, Expect=2e-105]} {Dmel: FBgn0038295, Gyc88E, Guanylyl cyclase at 88E, [RH, Score=593, Expect=0.0]} {Celegans: WBGene00001551, gcy-31, Soluble guanylate cyclase gcy-31, [RH, Score=513, Expect=2e-174]} {Smed: dd_Smed_v6_18111_0_1, dd_Smed_v6_18111_0_1, [RH, Score=823, Expect=0.0]} {RNA1509_55074} {RNA1310_24262} {RNA815_41754} |
93. | MligTC455_20380 | 13 | 0.26 | Mlig455_013452 | Neo: - Age: - |
PLSCR4 | 0.959 | - | - | 0.959 | - | - | - | Mlig455_013452 {REF} {Length: 2157} {Pfam: Scramblase [PF03803.17, score=94.3]} {Human: ENSG00000114698, PLSCR4, phospholipid scramblase 4, [Score=87.4, Expect=1e-18]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=87.0, Expect=1e-18]} {Celegans: WBGene00011935, scrm-1, Phospholipid scramblase, [Score=80.1, Expect=1e-16]} {Smed: dd_Smed_v6_4312_0_1, dd_Smed_v6_4312_0_1, [Score=65.5, Expect=4e-12]} {RNA1509_29015} {RNA1310_32034} {RNA815_51815} |
94. | MligTC455_24949 | 24 | 0.51 | Mlig455_053970 | Neo: - Age: Up-Down-Down |
AHNAK | 0.959 | - | - | 0.959 | - | - | - | Mlig455_053970 {REF} {Length: 8177} {Pfam: Herpes virus major outer envelope glycoprotein (BLLF1) [PF05109.15, score=19.9]} {Human: ENSG00000124942, AHNAK, AHNAK nucleoprotein, [Score=142, Expect=9e-33]} {Mouse: ENSMUSG00000069833, Ahnak, AHNAK nucleoprotein (desmoyokin), [Score=136, Expect=3e-31]} {Dmel: FBgn0259108, futsch, [Score=57.0, Expect=3e-07]} {Smed: dd_Smed_v6_9830_0_1, dd_Smed_v6_9830_0_1, [Score=52.0, Expect=3e-06]} {RNA1509_39227} {RNA1310_19750.1} {RNA815_47018} |
95. | MligTC455_35735 | 24 | 0.5 | Mlig455_016835, Mlig455_016847 | Neo: - Age: - |
0.959 | - | - | 0.959 | - | - | - | Mlig455_016835 {REF} {Length: 1740} {RNA1310_88085} Mlig455_016847 {REF} {Length: 1571} {RNA1310_88085} |
|
96. | MligTC455_43433 | 11 | 0.22 | Mlig455_048572 | Neo: - Age: - |
0.959 | - | - | 0.959 | - | - | - | Mlig455_048572 {REF} {Length: 3129} {Pfam: Peptidase family M13 [PF05649.15, score=24.6]} | |
97. | MligTC455_47069 | 35 | 0.73 | Mlig455_060973 | Neo: - Age: - |
0.959 | - | - | 0.959 | - | - | - | Mlig455_060973 {REF} {Length: 878} | |
98. | MligTC455_47870 | 5 | 0.1 | Mlig455_028728 | Neo: - Age: Down-Up-Down |
FAM102B | 0.959 | - | - | 0.959 | - | - | - | Mlig455_028728 {REF} {Length: 4059} {TRANSSPLICED} {Pfam: N-terminal C2 in EEIG1 and EHBP1 proteins [PF10358.11, score=58.0]; Lipoprotein leucine-zipper [PF04728.15, score=18.9]} {Human: ENSG00000162636, FAM102B, family with sequence similarity 102 member B, [RH, Score=125, Expect=1e-30]} {Mouse: ENSMUSG00000040339, Fam102b, family with sequence similarity 102, member B, [RH, Score=124, Expect=2e-30]} {Dmel: FBgn0032938, CG8671, [RH, Score=149, Expect=8e-37]} {Celegans: WBGene00006368, sym-3, SYM-3B, [RH, Score=105, Expect=1e-24]} {Smed: dd_Smed_v6_5362_0_1, dd_Smed_v6_5362_0_1, [RH, Score=118, Expect=1e-28]} {RNA1509_25898} {RNA1310_24346} {RNA815_12822} |
99. | MligTC455_50410 | 31 | 0.64 | Mlig455_020239 | Neo: - Age: - |
GRIA2 | 0.959 | - | - | 0.959 | - | - | - | Mlig455_020239 {REF} {Length: 2096} {Pfam: Ligand-gated ion channel [PF00060.28, score=192.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=127.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=91.1]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=513, Expect=7e-173]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=496, Expect=3e-166]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=494, Expect=8e-167]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=491, Expect=1e-164]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=507, Expect=4e-171]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=497, Expect=4e-167]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=494, Expect=1e-165]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=491, Expect=1e-164]} {Dmel: FBgn0038837, CG3822, [Score=432, Expect=1e-142]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=459, Expect=5e-152]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [Score=528, Expect=2e-179]} {RNA1509_56139} {RNA1310_38868} {RNA815_32684} |
100. | MligTC455_04854 | 57 | 1.18 | Mlig455_032030 | Neo: - Age: - Region-enriched R2: 5.099/0.03475 |
0.958 | - | - | 0.958 | - | - | - | Mlig455_032030 {REF} {Length: 1388} {RNA1310_84273} |